Finanziamento per ricerca clinica: partecipazione allo studio MULTICENTRE NON-INTERVENTIONAL POST-AUTHORIZATION SAFETY STUDY (NI-PASS) TO MONITOR THE INCIDENCE OF RELEVANT DRUG-RELATED ADVERSE EVENTS AND EPOETIN-RELATED LACK OF EFFICACY AMONG CKD PATIENTS